UPDATE: Raymond James Downgrades Teva Pharma (TEVA) to Market Perform
Tweet Send to a Friend
(Updated - October 28, 2021 5:17 AM EDT)
Raymond James analyst Elliot Wilbur downgraded Teva Pharma (NYSE: TEVA) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Raymond James analyst Elliot Wilbur downgraded Teva Pharma (NYSE: TEVA) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
